Literature DB >> 19188441

Distinct protein arginine methyltransferases promote ATP-dependent chromatin remodeling function at different stages of skeletal muscle differentiation.

Caroline S Dacwag1, Mark T Bedford, Saïd Sif, Anthony N Imbalzano.   

Abstract

Temporal regulation of gene expression is a hallmark of cellular differentiation pathways, yet the mechanisms controlling the timing of expression for different classes of differentiation-specific genes are not well understood. We previously demonstrated that the class II arginine methyltransferase Prmt5 was required for skeletal muscle differentiation at the early stages of myogenesis (C. S. Dacwag, Y. Ohkawa, S. Pal, S. Sif, and A. N. Imbalzano, Mol. Cell. Biol. 27:384-394, 2007). Specifically, when Prmt5 levels were reduced, the ATP-dependent SWI/SNF chromatin-remodeling enzymes could not interact with or remodel the promoter of myogenin, an essential early gene. Here we investigated the requirement for Prmt5 and the class I arginine methyltransferase Carm1/Prmt4 in the temporal control of myogenesis. Both arginine methyltransferases could bind to and modify histones at late-gene regulatory sequences. However, the two enzymes showed sequential requirements for gene expression. Prmt5 was required for early-gene expression but dispensable for late-gene expression. Carm1/Prmt4 was required for late- but not for early-gene expression. The reason for the requirement for Carm1/Prmt4 at late genes was to facilitate SWI/SNF chromatin-remodeling enzyme interaction and remodeling at late-gene loci. Thus, distinct arginine methyltransferases are employed at different times of skeletal muscle differentiation for the purpose of facilitating ATP-dependent chromatin-remodeling enzyme interaction and function at myogenic genes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188441      PMCID: PMC2655603          DOI: 10.1128/MCB.00742-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Methylation of SPT5 regulates its interaction with RNA polymerase II and transcriptional elongation properties.

Authors:  Youn Tae Kwak; Jun Guo; Shashi Prajapati; Kyu-Jin Park; Rama M Surabhi; Brady Miller; Peter Gehrig; Richard B Gaynor
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

2.  A methylation-mediator complex in hormone signaling.

Authors:  Wei Xu; Helen Cho; Shilpa Kadam; Ester M Banayo; Scott Anderson; John R Yates; Beverly M Emerson; Ronald M Evans
Journal:  Genes Dev       Date:  2004-01-16       Impact factor: 11.361

3.  Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential.

Authors:  Charlotte A Berkes; Donald A Bergstrom; Bennett H Penn; Karen J Seaver; Paul S Knoepfler; Stephen J Tapscott
Journal:  Mol Cell       Date:  2004-05-21       Impact factor: 17.970

4.  Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes.

Authors:  Sharmistha Pal; Sheethal N Vishwanath; Hediye Erdjument-Bromage; Paul Tempst; Saïd Sif
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

5.  The coactivator-associated arginine methyltransferase is necessary for muscle differentiation: CARM1 coactivates myocyte enhancer factor-2.

Authors:  Shen Liang Chen; Kelly A Loffler; Dagang Chen; Michael R Stallcup; George E O Muscat
Journal:  J Biol Chem       Date:  2001-11-16       Impact factor: 5.157

6.  Expression of a single transfected cDNA converts fibroblasts to myoblasts.

Authors:  R L Davis; H Weintraub; A B Lassar
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

7.  mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad.

Authors:  Sharmistha Pal; Romy Yun; Antara Datta; Lynne Lacomis; Hediye Erdjument-Bromage; Jitendra Kumar; Paul Tempst; Saïd Sif
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

8.  Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter.

Authors:  Raphaël Métivier; Graziella Penot; Michael R Hübner; George Reid; Heike Brand; Martin Kos; Frank Gannon
Journal:  Cell       Date:  2003-12-12       Impact factor: 41.582

9.  Loss of CARM1 results in hypomethylation of thymocyte cyclic AMP-regulated phosphoprotein and deregulated early T cell development.

Authors:  Jeesun Kim; Jaeho Lee; Neelu Yadav; Qi Wu; Carla Carter; Stéphane Richard; Ellen Richie; Mark T Bedford
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

10.  p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci.

Authors:  Cristiano Simone; Sonia Vanina Forcales; David A Hill; Anthony N Imbalzano; Lucia Latella; Pier Lorenzo Puri
Journal:  Nat Genet       Date:  2004-06-20       Impact factor: 38.330

View more
  56 in total

Review 1.  New insights into the epigenetic control of satellite cells.

Authors:  Viviana Moresi; Nicoletta Marroncelli; Sergio Adamo
Journal:  World J Stem Cells       Date:  2015-07-26       Impact factor: 5.326

2.  Molecular characterization, phylogenetic analysis and expression patterns of five protein arginine methyltransferase genes of channel catfish, Ictalurus punctatus (Rafinesque).

Authors:  Hung-Yueh Yeh; Phillip H Klesius
Journal:  Fish Physiol Biochem       Date:  2012-08       Impact factor: 2.794

Review 3.  The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.

Authors:  Nicole Stopa; Jocelyn E Krebs; David Shechter
Journal:  Cell Mol Life Sci       Date:  2015-02-07       Impact factor: 9.261

4.  Protein arginine methyltransferase biology in humans during acute and chronic skeletal muscle plasticity.

Authors:  Tiffany L vanLieshout; Jacob T Bonafiglia; Brendon J Gurd; Vladimir Ljubicic
Journal:  J Appl Physiol (1985)       Date:  2019-08-01

Review 5.  Promoting developmental transcription.

Authors:  Uwe Ohler; David A Wassarman
Journal:  Development       Date:  2010-01       Impact factor: 6.868

6.  Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2.

Authors:  Andrea Hadjikyriacou; Yanzhong Yang; Alexsandra Espejo; Mark T Bedford; Steven G Clarke
Journal:  J Biol Chem       Date:  2015-05-15       Impact factor: 5.157

Review 7.  Analysis of epigenetic alterations to chromatin during development.

Authors:  Meghan E Minard; Abhinav K Jain; Michelle Craig Barton
Journal:  Genesis       Date:  2009-08       Impact factor: 2.487

8.  Coactivator-associated arginine methyltransferase 1 regulates fetal hematopoiesis and thymocyte development.

Authors:  Jia Li; Ziqin Zhao; Carla Carter; Lauren I R Ehrlich; Mark T Bedford; Ellen R Richie
Journal:  J Immunol       Date:  2012-12-17       Impact factor: 5.422

9.  Crosstalk between C/EBPbeta phosphorylation, arginine methylation, and SWI/SNF/Mediator implies an indexing transcription factor code.

Authors:  Elisabeth Kowenz-Leutz; Ole Pless; Gunnar Dittmar; Maria Knoblich; Achim Leutz
Journal:  EMBO J       Date:  2010-01-28       Impact factor: 11.598

10.  Disruption of histone modification and CARM1 recruitment by arsenic represses transcription at glucocorticoid receptor-regulated promoters.

Authors:  Fiona D Barr; Lori J Krohmer; Joshua W Hamilton; Lynn A Sheldon
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.